Studies have shown that the antioxidant activity of HO-1 is particular pronounced in cardiovascular diseases such as atherosclerosis, ischemic heart disease, and hypertension, as well as in neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and cerebral ischemic injury [34]. Here, HMOX1 is linked to early-onset autosomal dominant Alzheimer disease.